Product dose omission: FDA reporting patterns
65,353 FDA FAERS reports mention Product dose omission. 15,985 reports have a serious outcome flag.
Medicines named as suspect
- Apremilast: 4,567 reports
- Dupilumab: 2,728 reports
- Fluticasone: 2,102 reports
- Albuterol: 1,745 reports
- Ustekinumab: 1,653 reports
- Insulin Glargine: 1,538 reports
- Etanercept: 1,414 reports
- Lenalidomide: 1,400 reports
- Ruxolitinib: 1,373 reports
- Alirocumab: 1,354 reports
- Dimethyl Fumarate: 1,248 reports
- Vilanterol: 1,246 reports
FAERS reports describe events reported after a medicine was taken. They do not prove that the medicine caused an event, measure how often a side effect occurs, or estimate personal risk.
Source: FDA FAERS via openFDA. FAERS data through 2026-06-30. Sources, methods, and limitations.